Opening act — London Life Sciences Week
Onyx Global
Life Sciences Forum
Where capital meets science & policy meets pace
Executives, investors, policymakers, scientists & students — one room, two days.
Get TicketsCore Themes
Three forces shaping life sciences
Capital Allocation
Where is smart money moving in biotech? We examine how capital is being deployed across therapeutic areas, geographies, and modalities — and whether the math adds up.
Pharma-Biotech Partnerships
The partnership landscape is shifting from licensing deals to full acquisitions. We explore the new logic of pharma-biotech collaboration, and what founders and investors need to know.
Regulation & Speed to Clinic
How regulatory bodies across the US, EU, and UK are accelerating — or blocking — the path from discovery to patient. We map the timelines, track the bottlenecks, and ask what must change.
About Onyx
Building the signal layer for life sciences
Onyx is a research intelligence company focused on biotech, pharma, and the life sciences investment ecosystem. We produce original analysis, host high-conviction events, and operate tools that help decision-makers move faster with better information.
Limited to ~1,000 attendees. Reserve your place early.
Get TicketsAttendees from
A different kind of life sciences event.
Get TicketsProgramme
Two days. Two frontiers. No filler.
Cell & Gene Therapies
I. The State of Biotech Capital
Where funding is flowing, where it's drying up, and what the LP-GP-founder dynamic looks like heading into 2027.
II. Manufacturing & Supply Chain
Autologous vs. allogeneic scale-up, viral vector bottlenecks, and the economics of getting CGTs to patients at commercial scale.
III. Regulatory Pathways for Advanced Therapies
ATMP frameworks, accelerated approvals, and what the FDA-EMA-MHRA divergence means for gene therapy sponsors.
Small Molecules & Biologics
IV. Drug Pricing & Market Access
IRA fallout, NICE reform, and the global pricing chessboard. What investors and pharma execs are actually modelling.
V. The Partnership Equation
M&A vs. licensing vs. co-development. How the pharma-biotech deal landscape is being redrawn.
VI. AI, Data & the New R&D Stack
From target identification to clinical trial optimisation. Separating the signal from the hype in computational biology.
Be part of the programme. Applications now open.
The Protocol
How this day works
Arrive with context
Every registered attendee receives a pre-forum briefing pack — original Onyx research, data snapshots, and speaker briefs. You arrive knowing the terrain.
Hear from leaders
Six curated sessions with founders, investors, regulators, and scientists. No sponsor slots. No filler. Every minute earns its place on the stage.
Enter the week better prepared
The Forum is designed as the opening act. You leave with sharper conviction, new relationships, and a framework for the week of meetings ahead.
Access
Choose your path in
All passes include full-day access, the pre-forum briefing pack, and post-event materials.
- Priority seating & front-row access
- Exclusive networking reception
- 1-to-1 meeting scheduling
- Private briefing with Onyx analysts
- Full post-event research report
- Full-day general admission
- Networking breaks & lunch
- Access to all six sessions
- Pre-forum briefing pack
- Digital post-event materials
- Full-day general admission
- Dedicated student networking hour
- Mentorship matching (limited)
- Pre-forum briefing pack
- Career resources from Onyx